Ingredients Insider - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ingredients Insider

The Mainstreaming of Continuous Flow API Synthesis

July 2, 2014

Pharmaceutical Technology

The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing.

Seeking Alternative Catalyst Solutions

June 2, 2014

Pharmaceutical Technology

Transition metal-containing catalysts are widely used in organic synthesis, but many are based on expensive, rare metals. Researchers are seeking more sustainable alternatives.

Scientific Advances in Cocrystals are Offset by Regulatory Uncertainty

May 2, 2014

Pharmaceutical Technology

Drug developers are taking a wait-and-see approach to the use of cocrystals.

Appropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs

April 2, 2014

Pharmaceutical Technology

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Synthetic Biology: The Next Frontier in Chiral Chemistry for API Synthesis

March 2, 2014

Pharmaceutical Technology

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.

A Look Ahead for Custom Manufacturing and Pharma

January 2, 2014

Pharmaceutical Technology

Emerging markets are an engine for growth in the custom-manufacturing and pharma markets.

Tracking Innovation in New Molecular Entities of 2013

December 2, 2013

Pharmaceutical Technology

A review of this year's crop of the new molecular entities and new biologics license applications approved by FDA thus far in 2013.

Applying Catalysis to Optimize API Synthesis

November 2, 2013

Pharmaceutical Technology

Fine-chemical companies, contract manufacturers, and researchers advance chemocatalysis and biocatalysis.

Advancing Chiral Chemistry in Pharmaceutical Synthesis

September 2, 2013

Pharmaceutical Technology

Developments involve stereoretentive cross-coupling, enantioselective alcohol silylation, strategies for amplifying signals in circular dichroism spectroscopy, and a synthetic route for the natural product ingenol.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here